Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose. The Company developed NARCANÂŽ (naloxone hydrochloride) Nasal Spray (âNARCANÂŽâ), a treatment to reverse opioid overdose. This product was conceived and developed by the Company, licensed to Adapt Pharma Operations Limited (âAdaptâ), an Ireland based pharmaceutical company in December 2014 and approved by the U.S. Food and Drug Administration (âFDAâ) in November 2015. It is marketed by Adapt. In October 2018, Emergent BioSolutions, Inc. ("EBS") completed its acquisition of Adapt. The Company's current pipeline includes medicines in development for Opioid Overdose Reversal (âOORâ), Alcohol Use Disorder (âAUDâ), Opioid Use Disorder (âOUDâ), and Acute Cannabinoid Overdose (âACOâ). The Company is also pursuing other treatment opportunities within the addiction and drug overdose field. Source
No articles found.
MorphoSys (FSE & NASDAQ: MOR) is a clinical-stage biopharmaceutical company dedica...
MorphoSys (FSE & NASDAQ: MOR) is a clinical-sta...
Microbotâ˘, which was founded in 2010 and commenced operations in 2011, became a ...
Microbotâ˘, which was founded in 2010 and comm...
Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is...
Merrimack is a biopharmaceutical company based ...
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-centric biotechnology comp...
Amicus Therapeutics (Nasdaq: FOLD) is a global,...
TCR² is an innovative immunotherapy company developing the next generation of T c...
TCR² is an innovative immunotherapy company de...
At Insmed we are on a mission to transform the lives of patients battling serious ...
At Insmed we are on a mission to transform the ...
We exist to make the first step in a familys path to recovery the right step thro...
We exist to make the first step in a familys p...
Join the National Investor Network and get the latest information with your interests in mind.